Go offline with the Player FM app!
Bleeding Heart: Apixaban for Atrial Fibrillation in ESRD & Safety of Smoking Cessation Medications
Archived series ("Inactive feed" status)
When? This feed was archived on August 27, 2019 01:29 (). Last successful fetch was on June 30, 2019 14:25 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 218795555 series 100081
Christopher Giuliano, Internal Medicine clinical pharmacist, hosts this week’s episode of The Rounds Table alongside Amber Lanae Martirosov, clinical pharmacist in ambulatory care with a focus on pulmonology. Both guests join us from Wayne State University. In this episode they cover the use of apixaban in patients with atrial fibrillation and end-stage renal disease (ESRD) on hemodialysis, and the cardiovascular safety of medications used for smoking cessation.
Dabigatran and rivaroxaban, two direct oral anticoagulants (DOACs), can increase bleeding risk compared to warfarin in hemodialysis patients. Does apixaban have similar risks? Christopher walks listeners through a cohort study of patients with atrial fibrillation on hemodialysis receiving apixaban compared to warfarin. The study compares the risks of stroke, systemic embolism, bleeding, and mortality.
By prescribing agents for smoking cessation, physicians aim to lower patients’ overall cardiovascular risk. But what if the opposite occurs, and risk is increased with these medications? The EAGLES trial (Evaluating Adverse Events in a Global Smoking Cessation Study) was initially designed to study the neuropsychiatric effects smoking cessation agents. Amber reviews an extension of this trial, and covers the cardiovascular safety of varenicline, bupropion, and the nicotine patch in patients who smoke compared to placebo.
Finally, the Good Stuff segment. Christopher shares an article on bleeding risk with selective serotonin reuptake inhibitors (SSRI’s) and Amber shares an article on chronic versus as-needed inhaled corticosteroid/long-acting-beta-agonist (ICS/LABA) use for mild persistent asthma.
Like what you hear? Rate us on iTunes! Chat with us on Twitter at @roundstable and tweet at Wayne State University @waynestate and Wayne State Pharmacy @WSUPharmD.
Interested in helping us evaluate our podcast episodes? We’re currently recruiting a panel of residents to serve as regular reviewers for the show. If you’re interested, email wkwong@qmed.ca.
The Papers
1. Apixaban in ESRD: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.118.035418?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
2. Safety of Smoking Cessation Agents: https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2677060
Good Stuff
1. SSRI’s and Bleeding Risk: http://journals.sagepub.com/doi/full/10.1177/1060028018794005
2. Mild Persistent Asthma:https://www.nejm.org/doi/full/10.1056/NEJMoa1715275
Music Credits
The Rounds Table Theme Music by Brendan Quinn, Creative Director and Composer, Vapor RMW
The post Bleeding Heart: Apixaban for Atrial Fibrillation in ESRD & Safety of Smoking Cessation Medications appeared first on Healthy Debate.
258 episodes
Archived series ("Inactive feed" status)
When? This feed was archived on August 27, 2019 01:29 (). Last successful fetch was on June 30, 2019 14:25 ()
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 218795555 series 100081
Christopher Giuliano, Internal Medicine clinical pharmacist, hosts this week’s episode of The Rounds Table alongside Amber Lanae Martirosov, clinical pharmacist in ambulatory care with a focus on pulmonology. Both guests join us from Wayne State University. In this episode they cover the use of apixaban in patients with atrial fibrillation and end-stage renal disease (ESRD) on hemodialysis, and the cardiovascular safety of medications used for smoking cessation.
Dabigatran and rivaroxaban, two direct oral anticoagulants (DOACs), can increase bleeding risk compared to warfarin in hemodialysis patients. Does apixaban have similar risks? Christopher walks listeners through a cohort study of patients with atrial fibrillation on hemodialysis receiving apixaban compared to warfarin. The study compares the risks of stroke, systemic embolism, bleeding, and mortality.
By prescribing agents for smoking cessation, physicians aim to lower patients’ overall cardiovascular risk. But what if the opposite occurs, and risk is increased with these medications? The EAGLES trial (Evaluating Adverse Events in a Global Smoking Cessation Study) was initially designed to study the neuropsychiatric effects smoking cessation agents. Amber reviews an extension of this trial, and covers the cardiovascular safety of varenicline, bupropion, and the nicotine patch in patients who smoke compared to placebo.
Finally, the Good Stuff segment. Christopher shares an article on bleeding risk with selective serotonin reuptake inhibitors (SSRI’s) and Amber shares an article on chronic versus as-needed inhaled corticosteroid/long-acting-beta-agonist (ICS/LABA) use for mild persistent asthma.
Like what you hear? Rate us on iTunes! Chat with us on Twitter at @roundstable and tweet at Wayne State University @waynestate and Wayne State Pharmacy @WSUPharmD.
Interested in helping us evaluate our podcast episodes? We’re currently recruiting a panel of residents to serve as regular reviewers for the show. If you’re interested, email wkwong@qmed.ca.
The Papers
1. Apixaban in ESRD: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.118.035418?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
2. Safety of Smoking Cessation Agents: https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2677060
Good Stuff
1. SSRI’s and Bleeding Risk: http://journals.sagepub.com/doi/full/10.1177/1060028018794005
2. Mild Persistent Asthma:https://www.nejm.org/doi/full/10.1056/NEJMoa1715275
Music Credits
The Rounds Table Theme Music by Brendan Quinn, Creative Director and Composer, Vapor RMW
The post Bleeding Heart: Apixaban for Atrial Fibrillation in ESRD & Safety of Smoking Cessation Medications appeared first on Healthy Debate.
258 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.